Accendra Health (ACH) Revenue & Revenue Breakdown
Accendra Health Revenue Highlights
Latest Revenue (Y)
$10.70B
Latest Revenue (Q)
$697.26M
Main Segment (Y)
Products & Healthcare Services
Main Geography (Y)
UNITED STATES
Accendra Health Revenue by Period
Accendra Health Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $10.70B | 3.55% |
| 2023-12-31 | $10.33B | 3.80% |
| 2022-12-31 | $9.96B | 1.74% |
| 2021-12-31 | $9.79B | 15.39% |
| 2020-12-31 | $8.48B | -7.93% |
| 2019-12-31 | $9.21B | -2.20% |
| 2018-12-31 | $9.42B | 1.07% |
| 2017-12-31 | $9.32B | -4.17% |
| 2016-12-31 | $9.72B | -0.51% |
| 2015-12-31 | $9.77B | 3.52% |
| 2014-12-31 | $9.44B | 4.06% |
| 2013-12-31 | $9.07B | 1.83% |
| 2012-12-31 | $8.91B | 3.25% |
| 2011-12-31 | $8.63B | 6.21% |
| 2010-12-31 | $8.12B | - |
Accendra Health generated $10.70B in revenue during NA 2024, up 3.55% compared to the previous quarter, and up 116.18% compared to the same period a year ago.
Accendra Health Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $697.26M | 2.25% |
| 2025-06-30 | $681.92M | -74.09% |
| 2025-03-31 | $2.63B | -2.37% |
| 2024-12-31 | $2.70B | 292.53% |
| 2024-09-30 | $686.85M | 4.00% |
| 2024-06-30 | $660.40M | 3.54% |
| 2024-03-31 | $637.84M | -75.99% |
| 2023-12-31 | $2.66B | 2.49% |
| 2023-09-30 | $2.59B | 1.11% |
| 2023-06-30 | $2.56B | 1.60% |
| 2023-03-31 | $2.52B | -1.11% |
| 2022-12-31 | $2.55B | 2.15% |
| 2022-09-30 | $2.50B | -0.10% |
| 2022-06-30 | $2.50B | 3.87% |
| 2022-03-31 | $2.41B | -2.44% |
| 2021-12-31 | $2.47B | -1.40% |
| 2021-09-30 | $2.50B | 0.51% |
| 2021-06-30 | $2.49B | 7.00% |
| 2021-03-31 | $2.33B | -1.49% |
| 2020-12-31 | $2.36B | 7.95% |
| 2020-09-30 | $2.19B | 21.03% |
| 2020-06-30 | $1.81B | -14.84% |
| 2020-03-31 | $2.12B | -3.10% |
| 2019-12-31 | $2.19B | -4.45% |
| 2019-09-30 | $2.29B | -3.53% |
| 2019-06-30 | $2.38B | 1.10% |
| 2019-03-31 | $2.35B | 10.76% |
| 2018-12-31 | $2.12B | -13.89% |
| 2018-09-30 | $2.46B | 0.27% |
| 2018-06-30 | $2.46B | 3.61% |
| 2018-03-31 | $2.37B | -0.72% |
| 2017-12-31 | $2.39B | 2.39% |
| 2017-09-30 | $2.33B | 3.00% |
| 2017-06-30 | $2.27B | -2.69% |
| 2017-03-31 | $2.33B | -1.68% |
| 2016-12-31 | $2.37B | -1.96% |
| 2016-09-30 | $2.42B | -2.74% |
| 2016-06-30 | $2.48B | 1.14% |
| 2016-03-31 | $2.46B | -1.29% |
| 2015-12-31 | $2.49B | 0.66% |
| 2015-09-30 | $2.47B | 2.04% |
| 2015-06-30 | $2.42B | 1.30% |
| 2015-03-31 | $2.39B | -4.04% |
| 2014-12-31 | $2.49B | 4.43% |
| 2014-09-30 | $2.39B | 3.48% |
| 2014-06-30 | $2.31B | 2.19% |
| 2014-03-31 | $2.26B | -2.68% |
| 2013-12-31 | $2.32B | 2.11% |
| 2013-09-30 | $2.27B | 0.17% |
| 2013-06-30 | $2.27B | -0.40% |
| 2013-03-31 | $2.28B | -2.12% |
| 2012-12-31 | $2.32B | 6.65% |
| 2012-09-30 | $2.18B | -0.25% |
| 2012-06-30 | $2.19B | -1.46% |
| 2012-03-31 | $2.22B | 1.00% |
| 2011-12-31 | $2.20B | 0.88% |
| 2011-09-30 | $2.18B | 2.13% |
| 2011-06-30 | $2.13B | 0.36% |
| 2011-03-31 | $2.12B | 2.59% |
| 2010-12-31 | $2.07B | - |
Accendra Health generated $697.26M in revenue during Q3 2025, up 2.25% compared to the previous quarter, and up 105.58% compared to the same period a year ago.
Accendra Health Revenue Breakdown
Accendra Health Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Patient Direct | $2.68B | $2.55B | $2.06B | - | - |
| Products & Healthcare Services | $8.02B | $7.78B | $7.90B | - | - |
| Global Solutions | - | - | - | $7.86B | $7.21B |
| Global Products | - | - | - | $2.66B | $1.81B |
Accendra Health's latest annual revenue breakdown by segment (product or service), as of Dec 24: Products & Healthcare Services (74.95%), and Patient Direct (25.05%).
Quarterly Revenue by Product
| Product/Service | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Urology | $28.98M | $28.70M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diabetes Product | $201.37M | $191.06M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Product and Service, Other | $72.59M | $72.30M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Wound Care | $48.00M | $46.82M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Patient Direct | - | - | $673.88M | $695.02M | $686.85M | $660.40M | $637.84M | $1.31B | $632.50M | $607.36M | $617.49M | $594.04M | $572.63M | $272.91M | - | - | - | - | - | - |
| Products & Healthcare Services | - | - | $1.96B | $2.00B | $2.03B | $2.01B | $1.97B | $3.94B | $1.93B | $1.92B | $1.93B | $1.90B | $1.93B | $2.13B | - | - | - | - | - | - |
| Rental Equipment | - | - | - | - | - | - | - | - | $158.00M | - | - | - | - | - | - | - | - | - | - | - |
| Global Products | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $629.34M | $679.07M | $688.57M | $658.75M | $574.94M |
| Global Solutions | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.01B | $2.02B | $1.98B | $1.85B | $1.95B |
Accendra Health's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Diabetes Product (57.38%), Product and Service, Other (20.68%), Wound Care (13.68%), and Urology (8.26%).
Accendra Health Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Non-US | $242.94M | $275.29M | $429.44M | $534.98M | $349.77M |
| UNITED STATES | $10.46B | $10.06B | $9.53B | $9.25B | $8.13B |
Accendra Health's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (97.73%), and Non-US (2.27%).
Quarterly Revenue by Country
| Country | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | $2.58B | $2.64B | $2.66B | $2.61B | $2.55B | $2.59B | $2.52B | $2.50B | $2.45B | $2.48B | $2.41B | $2.38B | $2.26B | $2.35B | $2.38B | $2.34B | $2.18B | $2.26B | $2.10B | $1.74B |
| Non-US | $51.33M | $59.22M | $59.66M | $62.00M | $62.07M | $67.90M | $72.79M | $64.69M | $69.91M | $74.45M | $86.61M | $123.44M | $144.93M | $117.04M | $121.38M | $152.79M | $143.78M | $103.57M | $86.85M | $70.10M |
Accendra Health's latest quarterly revenue breakdown by geography, as of Mar 25: UNITED STATES (98.05%), and Non-US (1.95%).
Accendra Health Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ACH | Accendra Health | $10.70B | $697.26M |
| HITI | High Tide | $487.67M | $124.26M |
| CGC | Canopy Growth | $297.15M | $83.00M |
| OM | Outset Medical | $113.69M | $29.43M |
| SGHT | Sight Sciences | $79.87M | $19.91M |
| CVRX | CVRx | $51.29M | $14.69M |
| ACRS | Aclaris Therapeutics | $18.72M | $3.30M |
| ALLO | Allogene Therapeutics | $22.00K | - |
| EDIT | Editas Medicine | - | - |
| CABA | Cabaletta Bio | - | - |
| BIOA | BioAge Labs | - | $2.05M |